Asceniv
Total Payments
$254,180
Transactions
34
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $254,180 | 34 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $254,180 | 34 | 100.0% |
Top Doctors Receiving Payments for Asceniv
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatric Hematology-Oncology | Salt Lake City, UT | $85,408 | 9 |
| , MD | Allergy & Immunology | Philadelphia, PA | $58,265 | 8 |
| , M.D | Specialist | Centennial, CO | $52,958 | 12 |
| , M.D | Allergy & Immunology | St Petersburg, FL | $23,172 | 1 |
| , MD | Pediatric Rheumatology | Gainesville, FL | $22,360 | 1 |
| , M.D., M.P.H | Pediatric Allergy/Immunology | Charleston, SC | $12,017 | 3 |
Ad
Manufacturing Companies
- ADMA BioManufacturing LLC $254,180
Product Information
- Type Drug
- Total Payments $254,180
- Total Doctors 6
- Transactions 34
About Asceniv
Asceniv is a drug associated with $254,180 in payments to 6 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is ADMA BioManufacturing LLC.
Payment data is available from 2023 to 2023. In 2023, $254,180 was paid across 34 transactions to 6 doctors.
The most common payment nature for Asceniv is "Unspecified" ($254,180, 100.0% of total).